Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-12-24
pubmed:abstractText
3D-QSAR studies comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were carried out on 26 structurally diverse subcutaneous pentylenetetrazol (scPTZ) active enaminone analogues, previously synthesized in our laboratory. CoMFA and CoMSIA were employed to generate models to define the specific structural and electrostatic features essential for enhanced binding to the putative GABA receptor. The 3D-QSAR models demonstrated a reliable ability to predict the CLogP of the active anticonvulsant enaminones, resulting in a q(2) of 0.558 for CoMFA, and a q(2) of 0.698 for CoMSIA. The outcomes of the contour maps for both models provide detailed insight for the structural design of novel enaminone derivatives as potential anticonvulsant agents.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-11170622, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-12161061, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-12593916, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-14689468, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-1495012, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-14998338, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-15186843, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-15248192, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-15530123, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-15912138, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-16219468, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-16392787, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-16650601, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-16789894, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-17416486, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-17621683, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-7562939, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-8243370, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-8336334, http://linkedlifedata.com/resource/pubmed/commentcorrection/19059784-9925291
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1464-3391
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
133-40
pubmed:dateRevised
2011-7-25
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Enaminones 8: CoMFA and CoMSIA studies on some anticonvulsant enaminones.
pubmed:affiliation
Department of Pharmaceutical Sciences, Howard University, Washington, DC 20059, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural